We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
- Authors
Creagan, E T; Suman, V J; Dalton, R J; Pitot, H C; Long, H J; Veeder, M H; Vukov, A M; Rowland, K M; Krook, J E; Michalak, J C
- Abstract
A prospective randomized phase III clinical trial was conducted to assess whether the addition of tamoxifen (TAM) to the three-agent regimen of cisplatin (CDDP), dacarbazine (DTIC), and carmustine (BCNU) significantly increased the progression-free survival and overall survival of patients with advanced malignant melanoma.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Vol 17, Issue 6, p1884
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1999.17.6.1884